{"prompt": "['3', '0.1: Signature Sheet', 'Protocol Authorized:', 'Stig Larsen\u00b9, Goran Petrovski\u00b2, Bj\u00f8rn Helland Hansen\u00b3 and Bard Dalhoi4', 'Qualifications:', '1. Project Manager, Professor; Controlled Clinical Trials Research Methodology and', 'Biostatistics', '2. Professor; Ophthalmology', '3. PhD-fellow; Ophthalmology', '4. Project Coordinator, CEO BulbiTech A/S', 'Signature 1', 'Date', 'Signature 2', 'Date', 'Signature 3', 'Date', 'Signature 4', 'Date', 'BulbiCam; Validity study:', 'V1_OTH/DR; AMD-I/2022:', 'Final Version 1.5 22nd March 2022']['4', '0.2: Contact names and addresses', 'Professor Stig Larsen; Clinical Research Methodology and Statistics', 'Project Manager, Norwegian University of Life Sciences / Meddoc A/S, Hvamstubben 14,', '2013 Skjetten', 'Phone +47 413 26 325', 'E-mail: sl@meddoc.no', 'Professor Goran Petrovski; Ophthalmology', 'Department of Ophthalmology, Oslo University Hospitals / Ulleval Hospital, Oslo', 'Phone: +47 9222 6158', 'E-mail: goran.petrovski@medisin.uio.no', 'Dr Bj\u00f8rn Helland Hansen', 'Chief Medical Officer (CMO)', 'BulbiTech AS, Dybdahlsveg 3 - 5, 7051 Trondheim', 'Phone: +47 412 35 584', 'E-mail: bjorn@bulbitech.com', 'Bard Dalhoi CEO BulbiTech AS', 'Project Coordinator', 'BulbiTech AS, Dybdahlsveg 3 - 5, 7051 Trondheim', 'Phone: +47 90 99 01 99', 'E-mail: bard@bulbitech.com', 'Dr Alexander Sverstad MD, Ophthalmologist', 'Department of Ophthalmology, Oslo University Hospitals / Ulleval Hospital, Oslo', 'Phone: +47 9946 1682', 'E-mail: alexsvers@gmail.com', 'Dr Henrik Skaret, Ophthalmologist', 'Department of Ophthalmology Helgeland Sykehus', 'Phone: -47 46446640', 'E-mail: henrik.skaret@gmail.com', 'Vivy L Larsen MSc', 'Data Manager (DM)', 'Meddoc AS, Hvamstubben 14, 2013 Skjetten', 'Phone: +47 412 93 161', 'E-mail: vll@meddoc.no', 'Hans E Fagertun MS', 'Statistician', 'Meddoc AS, Hvamstubben 14, 2013 Skjetten', 'Phone: +47 412 93 161', 'E-mail: hf@meddoc.no', 'Einar Kvam Lundberg BS', 'Data engineer/programmer', 'Meddoc AS, Hvamstubben 14, 2013 Skjetten', 'Phone: +47 951 79 012', 'E-mail: ekl@meddoc.no', 'BulbiCam; Validity study:', 'V1_OTH/DR; AMD-I/2022:', 'Final Version 1.5 22nd March 2022']['5', '0.3: List of Abbreviations', 'Abbreviation', 'Explanation', 'AE', 'Adverse Event', 'AMD', 'Age related macular degeneration', 'BCAM', 'Bulbicam', 'BSC', 'Bachelor of Science', 'EMP', 'Eye Movement Perimeter', 'CIOMS', 'Council for International Organizations of Medical Sciences', 'CSR', 'Clinical Study Report', 'CRD', 'Clinically Relevant Difference', 'CRF', 'Case Report Form', 'CTCAE', 'Common Terminology Criteria for Adverse Events', 'CV', 'Curriculum Vita', 'DA', 'Dark adaptation', 'DR', 'Diabetes retropathy', 'DM', 'Data Management', 'DME', 'Diabetic macular edema', 'EQ-5D-5L', 'QoL questionnaire', 'GCP', 'Good Clinical Practice', 'HC', 'Healthy Control', 'ITT', 'Intention to treat', 'LOCS', 'Lens Opacification classification system', 'LOCF', 'Last Observation Carried Forward', 'MSC', 'Master of Science', 'NPDR', 'non-proliferative stage', 'NSD', 'Norwegian Centre for Research data', 'OTH', 'Ophthalmology', 'OR', 'Odds Ratio', 'PCIOL', 'Posterior Chamber Artificial Ocular Lens', 'PDR', 'proliferative stage', 'PP', 'Per Protocol', 'PhNR', 'Photonic negative response', 'PDR', 'Proliferative DR', 'PIPR', 'Post-illumination pupil response', 'PSC', 'Posterior Sub Capsular', 'QoL', 'Quality of Life Questionnaire', 'RAPD', 'Relative Afferent Pupil Defect', 'REK', 'Regional Ethical Committee', 'SAE', 'Serious Adverse Event', 'SAS', 'Statistical Analysis System', 'SD', 'Standard Deviation', 'SFT', 'Swinging flashlight test', 'ST', 'Standard Method', 'SOC', 'System Organ Class', 'SURSAR', 'Suspected Unexpected Serious Adverse Reactions', 'VAS', 'Visual Analogue Scale', 'BulbiCam; Validity study:', 'V1_OTH/DR; AMD-I/2022:', 'Final Version 1.5 22nd March 2022']\n\n###\n\n", "completion": "END"}